December 2, 2024 - 18:47

Zscaler, Inc. has announced impressive financial results for the first quarter of fiscal 2025, showcasing significant growth across multiple key metrics. The company's revenue has surged by 26% year-over-year, reaching a total of $628.0 million. This robust growth reflects the increasing demand for Zscaler's cloud-based security solutions in an ever-evolving digital landscape.
In addition to revenue growth, calculated billings also saw a notable increase, rising 13% year-over-year to $516.7 million. This indicates strong customer engagement and a solid pipeline for future revenue. Deferred revenue, a critical indicator of future earnings, grew by 27% year-over-year, totaling $1,783.7 million, further demonstrating the company's ongoing success.
While Zscaler reported a GAAP net loss of $12.1 million, this is a marked improvement compared to a loss of $33.5 million in the same period last year. On a non-GAAP basis, the company achieved a net income of $124.3 million, up from $86.4 million year-over-year, underscoring its operational efficiency and financial health.
June 23, 2026 - 20:50
Bitcoin 'vulnerable to further weakness' as token tumbles amid tech routBitcoin took a sharp hit on Tuesday, falling in tandem with a broad sell-off in technology stocks that rattled global markets. The leading cryptocurrency dropped more than 5% in a single session,...
June 23, 2026 - 18:40
SpaceX stock dips below $150 debut before reboundingSpaceX`s stock took another hit on Tuesday, sliding below its initial public offering price of $150 before recovering later in the session. The sell-off extended a rough stretch for the company`s...
June 22, 2026 - 17:54
SpaceX stock tumbles 16.4%, shaving off most IPO gains since debutSpaceX shares took another sharp hit on Monday, putting the company on track for three consecutive days of losses. The steep decline has wiped out the majority of the gains the stock had racked up...
June 22, 2026 - 04:41
West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth NarrativeWest Pharmaceutical Services (WST) stock has drawn attention after recent share price moves, with investors weighing its role in drug containment and delivery in relation to current valuation...